Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Mid-range Performer
856.0000 -34.20 (-3.84%)
NSE Jan 12, 2026 11:50 AM
Volume: 406.5K
 

logo
Natco Pharma Ltd.
01 Jun 2021
856.00
-3.84%
Ashika Research
Natco Pharma Ltd. (NPL) is a midsized pharmaceutical company with a presence across the pharma value chain. It owns eight manufacturing facilities including six formulations facilities and two API facilities. The company also has a US retail business. Natco is a leading domestic player in the oncology space. NPL's product pipeline consists of drugs,...
Number of FII/FPI investors decreased from 317 to 235 in Sep 2025 qtr
More from Natco Pharma Ltd.
Recommended